1. Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine

2. Overview • What do we know about the prevalence of sight loss in the UK • What are the major conditions leading to sight loss? • Do we need more research? • What are the gaps in knowledge? • What are the main research questions arising from the data on prevalence and causes?

3. Use of prevalence data • Prevalence defined as proportion of people with sight loss at a specific time point • Describes the relative importance of a health problem in the population • Usually reported for different age groups • Prevalence rates applied to age specific population data provide estimates of number of people affected • Knowledge of prevalence and numbers by causes of sight loss is important for planning services and identifying unmet need

4. Prevalence estimates of sight loss are only the first step Largely uninformative without data on the underlying conditions leading to sight loss

5. Approaches to measurement and categorisation of sight loss • Vision difficulties Self report of difficulties with vision related functions ranging from single item questions to disability scales • Vision related quality of life scales Describe the impact of vision problems on everyday functioning and well-being • Clinical measures “Objective” measures eg Distance and near acuity, visual fields etc

6. Definition of visual impairment • WHO cut-points are based on best eye and after full refraction • Visual impairment <6/18 • Low vision <6/18 to 3/60 • Blindness <3/60 • Definitions used in UK studies • <6/12 (approximates to UK driving requirement) • <6/18 & <3/60 • Presenting or pinhole corrected or after refraction

7. Prevalence of best-corrected visual acuity <6/12 in population-based studies Congdon et al Arch Ophthalmol 1998

8. Surveys of adult population in the UK using visual acuity measurements

9. 74-79 80-84 85-89 90+ MRC Assessment Trial Prevalence of binocular visual impairment (<6/18) and blindness (<3/60)

10. UK studies: prevalence visual acuity

11. Comparison with other non UK studies: VA <6/18 in 75+

12. Variation in estimates between studies • Definitions • Measurement quality • Age structure • especially in oldest age groups where prevalence is highest • Sampling error • Small numbers in older age groups May be “true” differences between populations

13. What is the significance of differences in prevalence between populations? • Variations in prevalence reflect variation in the prevalence of underlying conditions • Availability and use of eye care services • Aetiology of specific eye problems in different populations

14. Comparison between UK and non UK studies • Most non UK studies use only best corrected visual acuity • Exclude data on vision impairment due to refractive error • Presenting vision is the most appropriate measure of a person’s everyday vision • Recommended by WHO in 2003 that presenting VA <6/18 be used as the main definition of visual impairment

15. MRC TrialCauses of visual impairment (VA <6/18) aged 75+ Prevalence of VA <6/18 excluding RE = 8%

16. Comparison with other studies – blindness (VA <3/60)

17. Comparison with other studies - low vision (VA <6/18-3/60)

18. Visual impairment in older people 50% to 70% of visual impairment in the older age group is due to “remediable” causes and could be improved by: specs/ new specs cataract surgery

19. Visual impairment in older people • Often not known to health services • Of people aged >65 (Reidy et al 1999): • only 12% of people with cataract were in touch with eye services • only one third of those with uncorrected refractive error had seen an optician in the past 12 months

20. MRC assessment trial • Of people eligible for referral to an ophthalmologist around a half were referred by the GP • Among those referred, 88% attended • Over 80% of people advised to see an optician did so • New lenses were obtained by 45% • The main reasons given for not obtaining glasses were ‘not needed’ and cost

21. Should new evidence on prevalence and causes of vision impairment be a research priority? • Probably not for the older age group. Evidence is reasonably consistent with other developed countries • Lack information on ethnic minorities in whom prevalence of VI, underlying causes and eye care use may be different from the majority population • Evaluation of strategies to reduce the high proportion of untreated remediable conditions should be priority for action